241 related articles for article (PubMed ID: 12070296)
1. Exploiting dendritic cells to improve vaccine efficacy.
Steinman RM; Pope M
J Clin Invest; 2002 Jun; 109(12):1519-26. PubMed ID: 12070296
[No Abstract] [Full Text] [Related]
2. Fully mobilizing host defense: building better vaccines.
Raychaudhuri S; Rock KL
Nat Biotechnol; 1998 Nov; 16(11):1025-31. PubMed ID: 9831030
[TBL] [Abstract][Full Text] [Related]
3. Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation.
Moody DB; Briken V; Cheng TY; Roura-Mir C; Guy MR; Geho DH; Tykocinski ML; Besra GS; Porcelli SA
Nat Immunol; 2002 May; 3(5):435-42. PubMed ID: 11938350
[TBL] [Abstract][Full Text] [Related]
4. CD1a in human cancers: a new role for an old molecule.
Coventry B; Heinzel S
Trends Immunol; 2004 May; 25(5):242-8. PubMed ID: 15099564
[No Abstract] [Full Text] [Related]
5. DNA vaccination: antigen presentation and the induction of immunity.
Shedlock DJ; Weiner DB
J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells.
Didierlaurent AM; Collignon C; Bourguignon P; Wouters S; Fierens K; Fochesato M; Dendouga N; Langlet C; Malissen B; Lambrecht BN; Garçon N; Van Mechelen M; Morel S
J Immunol; 2014 Aug; 193(4):1920-30. PubMed ID: 25024381
[TBL] [Abstract][Full Text] [Related]
7. The processing of antigens delivered as DNA vaccines.
Howarth M; Elliott T
Immunol Rev; 2004 Jun; 199():27-39. PubMed ID: 15233724
[TBL] [Abstract][Full Text] [Related]
8. Loading of the antigen-presenting protein CD1d with synthetic glycolipids.
Wallner FK; Chen L; Moliner A; Jondal M; Elofsson M
Chembiochem; 2004 Apr; 5(4):437-44. PubMed ID: 15185366
[TBL] [Abstract][Full Text] [Related]
9. TLR gateways to CD1 function.
Moody DB
Nat Immunol; 2006 Aug; 7(8):811-7. PubMed ID: 16855607
[TBL] [Abstract][Full Text] [Related]
10. Species-specific CD1-restricted innate immunity for the development of HIV vaccine.
Takahashi H
Vaccine; 2010 May; 28 Suppl 2():B3-7. PubMed ID: 20510740
[TBL] [Abstract][Full Text] [Related]
11. Modifying professional antigen-presenting cells to enhance DNA vaccine potency.
Hung CF; Yang M; Wu TC
Methods Mol Med; 2006; 127():199-220. PubMed ID: 16988456
[TBL] [Abstract][Full Text] [Related]
12. Biomaterials as vaccine adjuvants.
Jones KS
Biotechnol Prog; 2008; 24(4):807-14. PubMed ID: 19194892
[TBL] [Abstract][Full Text] [Related]
13. Targeted antigen delivery and activation of dendritic cells in vivo: steps towards cost effective vaccines.
Tacken PJ; Figdor CG
Semin Immunol; 2011 Feb; 23(1):12-20. PubMed ID: 21269839
[TBL] [Abstract][Full Text] [Related]
14. T-cell recognition of glycolipids presented by CD1 proteins.
Young DC; Moody DB
Glycobiology; 2006 Jul; 16(7):103R-112R. PubMed ID: 16597658
[TBL] [Abstract][Full Text] [Related]
15. Mediastinal lymph node CD8alpha- DC initiate antigen presentation following intranasal coadministration of alpha-GalCer.
Ko SY; Lee KA; Youn HJ; Kim YJ; Ko HJ; Heo TH; Kweon MN; Kang CY
Eur J Immunol; 2007 Aug; 37(8):2127-37. PubMed ID: 17615581
[TBL] [Abstract][Full Text] [Related]
16. A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model.
Gupta S; Termini JM; Rivas Y; Otero M; Raffa FN; Bhat V; Farooq A; Stone GW
Vaccine; 2015 Sep; 33(38):4798-806. PubMed ID: 26241951
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid DCs and cancer: a new role for an enigmatic cell.
Mohty M; Olive D; Gaugler B
Trends Immunol; 2004 Aug; 25(8):397-8; author reply 398-9. PubMed ID: 15275634
[No Abstract] [Full Text] [Related]
18. Dendritic cells in vivo: a key target for a new vaccine science.
Steinman RM
Immunity; 2008 Sep; 29(3):319-24. PubMed ID: 18799140
[TBL] [Abstract][Full Text] [Related]
19. Adjuvants may reduce in vivo transfection levels for DNA vaccination in mice leading to reduced antigen-specific CD8+ T cell responses.
Rose AH; Hoffmann FW; Hara JH; Urschitz J; Moisyadi S; Hoffmann PR; Bertino P
Hum Vaccin Immunother; 2015; 11(9):2305-11. PubMed ID: 26091088
[TBL] [Abstract][Full Text] [Related]
20. Approaches to improved targeting of DNA vaccines.
Wang G; Pan L; Zhang Y
Hum Vaccin; 2011 Dec; 7(12):1271-81. PubMed ID: 22108038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
